MtDNA germ line variation mediated ROS generates retrograde signaling and induces pro-cancerous metabolic features

Scientific Reports

Volumn 3, Issue , 2014, Pages

  Singh, Rajnish Kumar ^a   Srivastava, Archita ^a   Kalaiarasan, Ponnusamy ^b   Manvati, Siddharth ^b   Chopra, Rupali ^a   Bamezai, Rameshwar N K ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b SHRI MATA VAISHNO DEVI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; PYRUVATE KINASE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; BREAST TUMOR; CELL TRANSFORMATION; FEMALE; GENETICS; GERM CELL; HUMAN; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; SIGNAL TRANSDUCTION;

APOPTOSIS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DNA, MITOCHONDRIAL; FEMALE; GERM CELLS; HUMANS; OXIDATIVE STRESS; PYRUVATE KINASE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84938067663     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06571     Document Type: Article

References (56)

1. Galluzzi, L., Kepp, O., Trojel-Hansen, C. & Kroemer, G. Mitochondrial control of cellular life, stress, and death. Circ Res 111, 1198-1207 (2012).
2. Nunnari, J. & Suomalainen, A. Mitochondria: in sickness and in health. Cell 148, 1145-1159 (2012).
3. Woodson, J. D. & Chory, J. Coordination of gene expression between organellar and nuclear genomes. Nat Rev Genet 9, 383-395 (2008).
4. Anderson, S. et al. Sequence and organization of the human mitochondrial genome. Nature 290, 457-465 (1981).
5. Elliott, H. R., Samuels, D. C., Eden, J. A., Relton, C. L. & Chinnery, P. F. Pathogenic mitochondrial DNA mutations are commonin the general population.Am J Hum Genet 83, 254-260 (2008).
6. Dhillon, V. S. & Fenech, M. Mutations that affect mitochondrial functions and their association with neurodegenerative diseases. Mutat Res 759, 1-13 (2014).
7. Kazuno, A. A. et al. Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet 2, e128 (2006).
8. Wallace, D. C. A mitochondrial bioenergetic etiology of disease. J Clin Invest 123, 1405-1412 (2013).
9. Petros, J. A. et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A 102, 719-724 (2005).
10. Zhou, S. et al. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci U S A 104, 7540-7545 (2007).
11. Dasgupta, S., Hoque, M. O., Upadhyay, S. & Sidransky, D. Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Res 68, 700-706 (2008).
12. Lam, E. T. et al. Mitochondrial DNA sequence variation and risk of pancreatic cancer. Cancer Res 72, 686-695 (2012).
13. Gochhait, S., Bhatt, A., Sharma, S., Singh, Y. P., Gupta, P. & Bamezai, R. N. Concomitant presence of mutations in mitochondrial genome and p53 in cancer development-a study in north Indian sporadic breast and esophageal cancer patients. Int J Cancer 123, 2580-2586 (2008).
14. Darvishi, K., Sharma, S., Bhat, A. K., Rai, E. & Bamezai, R. N. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett 249, 249-255 (2007).
15. Li, X. Y., Guo, Y. B., Su, M., Cheng, L., Lu, Z. H. & Tian, D. P. Association of mitochondrial haplogroup D and risk of esophageal cancer in Taihang Mountain and Chaoshan areas in China. Mitochondrion 11, 27-32 (2011).
16. Booker, L. M. et al. North American white mitochondrial haplogroups in prostate and renal cancer. J Urol 175, 468-472; discussion 472-463 (2006).
17. Liu, V. W. et al. Mitochondrial DNA variant 16189T . C is associated with susceptibility to endometrial cancer. Hum Mutat 22, 173-174 (2003).
18. Arnold, R. S. et al. An inherited heteroplasmic mutation in mitochondrial gene COI in a patient with prostate cancer alters reactive oxygen, reactive nitrogen and proliferation. Biomed Res Int 2013, 239257 (2013).
19. Gonzalez-Vioque, E., Bornstein, B., Gallardo, M. E., Fernandez-Moreno, M. A. & Garesse, R. The pathogenicity scoring system for mitochondrial tRNA mutations revisited. Mol Genet Genomic Med 2, 107-114 (2014).
20. Galkin, A. et al. Identification of the mitochondrial ND3 subunit as a structural component involved in the active/deactive enzyme transition of respiratory complex I. J Biol Chem 283, 20907-20913 (2008).
21. van der Walt, J. M. et al. Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease. The American Journal of Human Genetics 72, 804-811 (2003).
22. van der Walt, J. M. et al. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365, 28-32 (2004).
23. Kato, T., Kunugi, H., Nanko, S. & Kato, N.Mitochondrial DNA polymorphisms in bipolar disorder. J Affect Disord 62, 151-164 (2001).
24. Juo, S. H. et al. A common mitochondrial polymorphism 10398A . G is associated metabolic syndrome in a Chinese population. Mitochondrion 10, 294-299 (2010).
25. Niemi, A.K. et al. A combination of three common inheritedmitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects. Eur J Hum Genet 13, 166-170 (2005).
26. Canter, J. A., Kallianpur, A. R., Parl, F. F. & Millikan, R. C. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 65, 8028-8033 (2005).
27. Covarrubias, D., Bai, R. K., Wong, L. J. & Leal, S. M. Mitochondrial DNA variant interactions modify breast cancer risk. J Hum Genet 53, 924-928 (2008).
28. Pezzotti, A., Kraft, P., Hankinson, S. E., Hunter, D. J., Buring, J. & Cox, D. G. The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk. PLoS One 4, e5356 (2009).
29. Czarnecka, A. M. et al. Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res Treat 121, 511-518 (2010).
30. Leslie, N. R., Bennett, D., Lindsay, Y. E., Stewart, H., Gray, A. & Downes, C. P. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J 22, 5501-5510 (2003).
31. Miki, H. & Funato, Y. Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species. J Biochem 151, 255-261 (2012).
32. Anastasiou, D. et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334, 1278-1283 (2011).
33. Bai, R. K., Leal, S. M., Covarrubias, D., Liu, A. & Wong, L. J. Mitochondrial genetic background modifies breast cancer risk. Cancer Res 67, 4687-4694 (2007).
34. McMahon, S. & Laframboise, T. Mutational patterns in the breast cancer mitochondrial genome, with clinical correlates. Carcinogenesis 35, 1046-1054 (2014).
35. Larman, T. C. et al. Spectrum of somatic mitochondrial mutations in five cancers. Proc Natl Acad Sci U S A 109, 14087-14091 (2012).
36. Chatterjee, A., Mambo, E. & Sidransky, D. Mitochondrial DNA mutations in human cancer. Oncogene 25, 4663-4674 (2006).
37. Nikolaev, A. I., Martynenko, A. V., Kalmyrzeav, B. B. & Tarantul, V. Z. Altered expression of mitochondrial GENES. Mol Med Rep 5, 1526-1530 (2001).
38. Ohta, S. Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs. Oncogene 25, 4768-4776 (2006).
39. Ogrunc, M. et al. Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation. Cell Death Differ 21, 998-1012 (2014).
40. Zhang, L. et al. Induction of apoptosis in human multiple myeloma cell lines by ebselen via enhancing the endogenous reactive oxygen species production. Biomed Res Int 2014, 696107 (2014).
41. Mittler, R. et al. ROS signaling: the new wave? Trends Plant Sci 16, 300-309 (2011).
42. Butow, R. A. & Avadhani, N. G. Mitochondrial signaling: the retrograde response. Mol Cell 14, 1-15 (2004).
43. Liu, Z. & Butow, R. A. Mitochondrial retrograde signaling. Annu Rev Genet 40, 159-185 (2006).
44. He, J. et al. Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation. EMBO Rep 13, 1116-1122 (2012).
45. Pal, R. et al. Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology. Mol Cancer 9, 303 (2010).
46. Finkel, T. Signal transduction by reactive oxygen species. J Cell Biol 194, 7-15 (2011).
47. Iqbal, M. A. et al. Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2. Mol Cancer 12, 72 (2013).
48. Iqbal, M. A. et al. Missense mutations in pyruvate kinase M2 promote cancer metabolism, oxidative endurance, anchorage independence, and tumor growth in a dominant negative manner. J Biol Chem 289, 8098-8105 (2014).
49. Ismail, R. S. et al. Differential gene expression between normal and tumor-derived ovarian epithelial cells. Cancer Res 60, 6744-6749 (2000).
50. Chaudhari, A. A., Seol, J. W., Kang, S. J. & Park, S. Y. Mitochondrial transmembrane potential and reactive oxygen species generation regulate the enhanced effect of CCCP on TRAIL-induced SNU-638 cell apoptosis. J Vet Med Sci 70, 537-542 (2008).
51. Kim, J. H. et al. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. Genome Res 21, 1028-1041 (2011).
52. Segref, A. et al. Pathogenesis of human mitochondrial diseases is modulated by reduced activity of the ubiquitin/proteasome system. Cell Metab 19, 642-652 (2014).
53. Torroni, A. et al. Classification of European mtDNAs from an analysis of three European populations. Genetics 144, 1835-1850 (1996).
54. Janssen, A. J. et al. Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clin Chem 53, 729-734 (2007).
55. Morrison, J. F. The activation of aconitase by ferrous ions and reducing agents. Biochem J 58, 685-692 (1954).
56. Akhtar, K., Gupta, V., Koul, A., Alam, N., Bhat, R. & Bamezai, R. N. Differential behavior of missense mutations in the intersubunit contact domain of the human pyruvate kinase M2 isozyme. J Biol Chem 284, 11971-11981 (2009).